Cipla Limited has informed the Exchange regarding a press release dated October 30, 2025, titled "Q2 FY26 Results".
Press Release Oct 30 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Cipla
- Cipla Expands Fall River Operations in USA, Announces Upcoming Hiring for Various Roles
- Press Release Jul 25 2025
- Press Release May 13 2025
- Press Release Jan 28 2025
- Press Release Oct 29 2024
Later from Cipla
- Cipla USA Strengthens Lung Leadership with Community Wellness Initiatives
- Press Release Jan 23 2026
- Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy
- Cipla strengthens US portfolio with the launch of generic Saxenda for weight management therapy
- Cipla strengthens US portfolio with the launch of generic Saxenda(R) (Liraglutide Injection) for weight management therapy
Follow Cipla into a list and get an email when it puts out news.
Follow Cipla